PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Allergy Clin Immunol. Author manuscript; available in PMC 2010 June 1.
Published in final edited form as:
PMCID: PMC2744461
NIHMSID: NIHMS104341

GREATER IN VITRO SUSCEPTIBILTY TO RHINOVIRUS INFECTION OF BRONCHIAL THAN NASAL AIRWAY EPITHELIAL CELLS FROM HUMAN SUBJECTS

Nilceia Lopez-Souza, M.D., Ph.D.,1 Silvio Favoreto, D.D.S., Ph.D.,2 Hofer Wong, B.S.,1 Theresa Ward, R.N.,1 Shigeo Yagi, Ph.D.,3 David Schnurr, M.D.,3 Walter E. Finkbeiner, M.D., Ph.D.,4 Gregory M. Dolganov, Ph.D.,5 Jonathan H Widdicombe, Ph.D.,6 Homer A. Boushey, M.D.,1 and Pedro C. Avila, M.D.2

Abstract

Background

Human rhinoviruses (HRVs) characteristically cause upper respiratory tract infection but they also infect the lower airways causing acute bronchitis and exacerbating asthma.

Objective

Our purpose was to study ex-vivo the differences in the response to HRV infection of nasal and bronchial epithelial cultures from the same healthy and asthmatic individuals, using conditions favoring development of fully differentiated pseudostratified mucociliary epithelium.

Methods

Cells from the inferior turbinates and bronchial tree of 5 healthy and 6 asthmatic individuals were cultured at an air-liquid interface. Cultures were infected with HRV-16 and after 48hrs the degree of infection was measured.

Results

Baseline median transepithelial resistance (Rte) was lower in human bronchial (HBE) than nasal (HNE) epithelial cell cultures (195Ω.cm2 [95%CI=164–252] vs 366Ω.cm2 [234–408] respectively, p<0.01). Virus replicated more easily in HBEs than HNEs based on virus shedding in apical wash (LogTCID50/0.1ml=2.0 [1.0–2.5] vs. 0.5 [0.5–1.5], p<0.01), and on a 20–30 fold greater viral load and number of infected cells in HBEs than in HNEs. The increases in expression of RANTES and protein kinase PKR were greater in HBE than in HNE cultures, as well as the concentrations of interleukin (IL)-8, IL-1α, RANTES and IP-10 in basolateral medium. However, no significant differences between asthmatic and healthy subjects (including interferon beta1 expression) were found.

Conclusions

Differentiated nasal epithelial cells may have mechanisms of increased resistance to rhinovirus infection compared with bronchial epithelial cells. We could not confirm previous reports of increased susceptibility to HRV infection in epithelial cells from asthmatic subjects.

Keywords: Human Rhinovirus, nasal and bronchial airway epithelial cells, air-liquid interface

INTRODUCTION

Infection with human rhinovirus (HRV) characteristically causes common colds, but may also provoke acute bronchitis in healthy people and exacerbate airway disease in people with asthma, cystic fibrosis, or chronic obstructive pulmonary disease 14.

The primary site of HRV infection in vivo is the airway epithelial cell 57. The involvement of the lower airways is likely due to direct infection of the bronchial mucosa because HRV RNA has been detected in tissues and secretions from the lower airways by application of polymerase chain reaction and in situ hybridization 79. Infection of epithelial cells with HRV in vitro induces secretion of a variety of cytokines and chemokines, including interleukin (IL)-1, IL-6, IL-8, IL-11, IP-10, GM-CSF, RANTES 10, 11 and interferon β1 (IFN-β1) 12. Because minimal or no discernible epithelial necrosis of sloughing are found in airway mucosal biopsies taken from people infected with HRV, or in cultures of airway epithelium infected in vitro, the symptoms of HRV infection are thought to reflect activation of host defense and inflammatory responses 7, 13.

In vivo, only a small proportion of cells are infected by HRV. Small and scattered foci of cells are infected in the upper 6, 14, 15 as well as lower airways 7. In primary bronchial and adenoidal epithelial cells cultured on solid supports and infected ex vivo, again only a small subset of the cells are infected 7, 16.

Reasoning that the severity of the response to HRV infection may be related to the number of cells infected and the number of HRV virions produced, we examined the hypothesis that susceptibility to HRV infection may differ between nasal and. bronchial epithelial cells from the same individual and between cells from asthmatic and healthy subjects.

Asthmatic subjects develop similar upper respiratory tract symptoms, but more severe symptoms of lower respiratory tract symptoms than healthy subjects during acute respiratory viral infections 17. A recent study reported that bronchial epithelial cells from asthmatic patients differ from those from healthy patients in supporting markedly greater viral replication and cell lysis, which was attributed to an impairment of virus-induced IFN-β1 production and induction of apoptosis 18. This study, like virtually all in vitro studies of the effects of HRV, used undifferentiated human airway epithelium, in which cells are grown to form a single cell layer submerged in medium. We have previously shown that poorly differentiated tracheal and nasal airway epithelial cells produced more infectious virus particles per cell, a seven-fold higher proportion of cells were infected, a 30–130 greater replication of HRV was supported and a 16-fold greater production of RANTES was induced than when the same cells were grown at an air-liquid interface 19. Air-liquid interface induces differentiation into a pseudostratified mucociliary epithelium closely resembling the in vivo appearance of native epithelium. Differentiation of airway epithelium therefore increases resistance to rhinovirus infection 19.

Because of the importance of the level of differentiation of airway epithelial cells as a determinant of their ex-vivo susceptibility to HRV infection, we undertook our study of differences in the response of nasal and bronchial epithelial cells from healthy and asthmatic subjects using only culture conditions favoring development of a normal-appearing mucociliary epithelium.

METHODS

Study subjects

Six subjects with allergic asthma and five healthy non-allergic subjects were studied (see Table I). Allergic status was determined by positive skin prick test (wheal >3mm with erythema and proper negative control reaction) to common allergens 20. Asthmatic subjects had diagnosis of asthma, bronchial hyperresponsiveness (PC20 methacholine < 8mg/ml) 20, were allergic to at least one allergen, and had mild to moderate disease as defined by the NIH guidelines 21. None had used inhaled corticosteroids for at least 4 weeks prior to enrollment. The healthy subjects had no previous history of lung disease, had normal spirometry and bronchial responsiveness to methacholine, and had no positive responses to skin prick tests. All subjects were non smokers. The study was approved by the University of California San Francisco’s Committee on Human Research, and written informed consent was obtained from all subjects.

Table I
Baseline characteristics of the subjects

Human Airway Cell culture and Cell infection

Nasal scrapings were performed as we previously described 22. Bronchial brushings were obtained by flexible Pentax bronchoscope (Model FB-18X; Pentax, Orangeburg, NY) using standard guidelines 23. The nasal (HNE) and bronchial (HBE) epithelial cell cultures were processed in parallel, and they were cultured at an air-liquid interface, as described previously 19, 22. See also the Methods section of the Online Repository at www jacionline.org.

Human rhinovirus-16 (HRV-16) passage 3 (grown from a stock sample from E. Dick and W. Busse, University of Wisconsin) with 1×106 tissue culture infectious dose of 50% (TCID50) per ml was added to the apical surface (multiplicity of infection=1.0), in triplicates. After 24h, viral suspension (or medium in control cells) was removed and the apical surface washed 3 times with PBS. Cells were then allowed to recover for 24 h, when the apical surface was washed with 200 to 300 μl of PBS, and this wash retained for titration of virus shedding. HRV was titrated in half-log dilutions of apical washes using confluent human fetal diploid lung cells (VRDL, Richmond, CA) and standard virology techniques 24. Rte and Vte were measured, and basolateral medium was collected and stored at −80 °C. Filters with attached cells were cut in halves. One half was placed in RLT buffer, vortexed for 10 seconds and frozen at −80°C for future RNA isolation. The other half was fixed in buffered 3.5% formaldehyde for 10 min and stored in PBS at 4°C for future histology.

LINCOplex human cytokine kits (Linco Research, St. Charles, MI) were used to measure levels of cytokines and chemokines in basolateral medium samples.

Gene expression and Immunocytochemistry

Two-step real-time RT-PCR method and immunofluorescence to HRV-16 were performed as described previously 25 (see more details in the Online Repository at www jacionline.org).

Statistical analysis

Shapiro-Wilk test for normality showed that the data were not normally distributed even if log transformed. Therefore, we used non-parametric statistics to analyze the data. We compared baseline characteristics in Table 1 using Mann Whitney rank sum test for continuous variables and Fisher exact test for sex. We analyzed data on inflammatory mediators using generalized estimating equations, which is a multivariate statistical test that allows simultaneous comparison of all characteristics of each culture (asthmatic or healthy group, nasal or bronchial site, and rhinovirus or sham infection) and also takes into account the subjects as sources for several replicate cultures. Differences were considered significant if the p value was < 0.05 using two-tailed tests. Data were analyzed using Stata 8 (College Station, TX).

RESULTS

Epithelial cell cultures

After 2 to 3 weeks of growth at an air-liquid interface (ALI), all nasal (HNE; n=70) and bronchial (HBE; n=84) epithelial cell cultures appeared fully confluent under the inverted microscope, developed properties resembling those of native epithelium, including an apical mucus layer and ciliated pseudostratified epithelium (see Figure 1), as well as permeability barrier, demonstrated by “dry” apical surface and development of transepithelial resistance (Rte), indicative of tight junction formation 22. Cultures also developed vectorial transport of ions, demonstrated by the transepithelial potential difference (Vte) and equivalent short circuit current (Ieq).

Figure 1
Light microscopy of epithelial cultures. Cross-sections of passage 1 nasal (A,B) and bronchial (C.D) epithelial cell cultures from control (A,C) and asthmatic (B,D) subjects grown at an air-liquid interface for 21 days and stained with hematoxylin and ...

Before HRV infection, Rte of nasal cell cultures was 366Ω.cm2 (234–408) (median; 95%CI); Rte of the bronchial cell cultures was 195Ω.cm2 (164–252) (p=0.0023). The values for Rte were closely similar for the cultures from the asthmatic and healthy subjects. Exposure to HRV-16 or sham led to similar and non-significant declines in Rte and transepithelial voltage at 48h in HNE and HBE cultures (see Results section of the Online Repository, which also contains the values for Vte and Ieq).

Virus replication in nasal and bronchial cell cultures

We first investigated susceptibility to HRV infection by quantifying HRV-16 viral load (RNA) in cell lysates using RT-PCR. There was a consistent and significant 20-to-30-fold greater HRV-16 replication in bronchial cell cultures (median = 12,279,579 relative gene copy number - RGCN; 95%CI = 9,051,454 to 20,010,944; n=46) than in nasal cell cultures (385,317 [258,999 to 1,287,758] n=39) in both groups (see Figure 2). The degree of infection was similar when comparing asthmatic versus healthy subjects.

Figure 2
HRV-16 replication on human nasal (HNE) and bronchial (HBE) epithelial cells measured by real-time PCR 48hs after viral inoculation. Intracellular HRV RNA load was higher in all infected compared to non-infected control cultures (*p<0.002, by ...

The titer of infectious rhinovirus shed in the apical wash of infected cells 48h after infection was significantly greater (p<0.01) in apical washes from the HBE cell cultures than in washes from HNE cell cultures (see Table II).. HRV shedding tended to be greater in HBEs from asthmatic subjects than HBEs from healthy subjects, but the difference was not statistically significant.

Table II
Viral shedding into apical side of nasal (HNE) and bronchial (HBE) epithelial cells infected with HRV-16 from asthmatics and healthy subjects.

By immunocytochemistry the number of HRV-16-infected cells was 5 to 30-fold higher in HBE than in HNE cultures. Essentially similar results were obtained in cultures from different subjects (duplicates of infected and controls). The average number of cells per field, viewed with confocal microscopy, was converted to the average number of cells per unit area of cell sheet. In bronchial cells exposed to virus, the number of positive cells was at least 20 times higher than control (see Figure 3). By contrast, nasal cells exposed to virus showed the number of positive cells to be insignificantly above background. In one experiment, there were 0 ± 0 positives per mm2 (mean ±SE) in control nasal cells, 5 ± 3 per mm2 in nasal cells exposed to virus, 0.6 ± 0.6 per mm2 in unexposed bronchial cells, and 175 ± 32 per mm2 in exposed bronchial cells. In a second experiment, background was higher, but the results were qualitatively the same: 20 ± 7/mm2 in control nasal cells, 29 ± 13/mm2 in exposed nasal, 9 ± 6/mm2 in control bronchial, and 152 ± 58 per mm2 in exposed bronchial cells.

Figure 3Figure 3
Immunocytochemistry for rhinovirus RNA (HRV-16). HRV-16 virus capsid protein 2 was stained with Cyanine 3 (CY-3, red) and nucleic acid were stained with YO-PRO®-1 iodide (green). A: Micrograph of non-infected control HBE cells showing no HRV-16. ...

Therefore, intracellular HRV-16 RNA load, apical shedding of infectious HRV-16 and immunocytochemistry count of cells infected with HRV-16 all showed that HBE cultures are about 20 times more susceptible to HRV-16 infection than HNE cultures.

Intercellular adhesion molecule-1 (ICAM-1) expression on upper and lower airway

To explore changes in expression of ICAM-1, the receptor for HRV-16, we analyzed mRNA of epithelial cell lysates. HRV-16 infection significantly increased expression of epithelial ICAM-1 mRNA by 1.2 to 1.4 fold in HBEs, but did not alter expression in HNEs (see Table III). There was no difference in ICAM-1 expression between uninfected HNEs and HBEs within group. However, comparison between groups showed that uninfected cells from healthy subjects expressed higher levels of ICAM-1 mRNA than cells from asthmatic subjects (p=0.04, GEE analysis).

Table III
mRNA expression of inflammatory markers in nasal (HNE) and bronchial (HBE) epithelial cells

Cytokine and chemokines mRNA expression after HRV infection

Consistent with our finding of low viral replication in HNE cultures infected with HRV-16, we found little change in mRNA for IL-6, IL-8, IL-1β, tumor necrosis factor α (TNFα), RANTES, or double-stranded RNA dependent protein kinase (PKR) after RV infection in these cells. In HBE cells, RV infection tended to increase expression of mRNA for ICAM-1, IL-8, RANTES, and PKR in both groups, but more markedly in asthmatic subjects (see Table III).

Cytokines and chemokines in basolateral medium

Largely consistent with the changes observed in mRNA expression, we found HRV-16 infection to induce significant production of IL-6, IL-1α, RANTES and IP-10 in samples from HBE cultures from both asthmatic and healthy subjects. HNE cultures did not have significant changes in production of these inflammatory mediators, except for RANTES in HNE cultures from healthy subjects (see Figure 4). There were again no differences in HBE cell production of these chemokines and cytokines between the asthmatic and healthy control groups.

Figure 4
Levels of interleukin (IL) -6, IL-1α, IP-10, RANTES in supernatants from HBE and HNE cultures collected 48h after HRV-16 (RV16) or sham (C, control) inoculation. Cultures from asthmatic (n=6) and healthy (n=5) subjects displayed similar results. ...

Anti-viral defense mechanisms

Prompted in part by a recent report of a striking difference in HRV activation of anti-viral defense mechanisms in bronchial epithelial cells from asthmatic and healthy subjects 18, 26, we examined changes in mRNA in HBE cultures from 4 asthmatics and 2 healthy subjects of our study for products involved in the type-1 interferon pathways, for defensins, pro-apoptosis genes for neuronal and inducible nitric oxide synthase 2A and 1 (NOS2A, NOS-1) and signal transducer and activator of transcription 1A (STAT1A).

We found that HRV infection caused upregulation of apoptosis genes (Caspase 3 and 7) in HBE cultures from asthmatics and also from healthy subjects. Likewise, there were increases in interferon- β1 (IFN-β1: asthmatic group 74.2 fold induction; p<0.001; Healthy: 9.4, p<0.001) STAT1A (9.4 fold vs. 5.6 p<0.001) and NOS2A (11.6 fold p=0.004 vs. 4.6, p=0.05) expressions after HRV infection (see Table E1, see Online Repository). Infected bronchial cultures from asthmatics had significant higher mean levels of IFN-β1 and STAT1A than cultures from healthy subjects (see table IV). These data contradict previous findings that asthmatic epithelial cells may be deficient in production of interferons and in induction of apoptosis after HRV infection.

DISCUSSION

The two major findings of this study are that bronchial epithelial cells are more susceptible to infection with HRV-16 than are nasal epithelial cells from the same subjects, and that cultures of either airway site from asthmatic subjects did not have higher response to HRV infection than cultures from healthy subjects. The first finding rejects our hypothesis that the predominance of upper airway symptoms with most rhinovirus infections is due to a greater susceptibility of nasal vs bronchial cells to HRV infection. Other factors must account for this, such as the site of deposition of infectious particles, whether transmitted by aerosol or by direct contact. Our second finding differs from those of previous investigators 18, who found bronchial epithelial cells from asthmatics to have greater susceptibility to HRV infection than bronchial epithelial cells from healthy volunteers. We believe the difference in our findings may be related to our practice of culturing cells at an air-liquid interface under conditions favoring development of a mucociliary epithelium resembling native epithelium in both structure (full confluence, formation of tight junctions and cilia) and function (electrical resistance, directional ion transport, mucus secretion) 19, 22. Under these conditions, we found no difference in the susceptibility to RV infection of nasal and bronchial epithelial cells of asthmatic vs. healthy subjects, but did find that in comparison to nasal epithelial cells, bronchial epithelial cells support 20–40 fold greater HRV-16 replication and release of infectious progeny at 24 hours, whether measured as copies viral RNA load, as number of infected cells or as titer of infectious HRV shedding in the apical surface (Fig 1). This greater growth of virus was accompanied by greater production of pro-inflammatory cytokines and chemokines.

Our findings extend those of previous studies showing that human rhinovirus can directly infect epithelial cells of the lower as well as the upper airway 27. A study using in situ hybridization showed HRV-16 to be present in epithelial cells of bronchial biopsies taken from volunteers after experimental infection with the virus 5, 6, 9. And several in vitro studies have shown HRV-16 to replicate well in human bronchial cells cultured on solid support and submerged in medium, which prevents differentiation 7, 9, 10. Under these culture conditions a study showed that non-differentiated squamous epithelial cells from the adenoids and bronchial epithelial cells obtained from different individuals were similarly susceptible to HRV infection 16. Our study differed because we collected upper and lower airway respiratory epithelial cells from the same subjects 22, eliminating the effect of individual variability in susceptibility to HRV infection. In addition, we studied differentiated cell cultures 28, 29, which resemble the native pseudocolumnar ciliated epithelium, but are more resistant to infection than undifferentiated single-layer cell cultures 19, 30. Undifferentiated cells resemble the basal cells of the pseudocolumnar epithelium. A recent study by Jakiela et al. has also demonstrated that basal cells from differentiated traqueobronchial epithelium are more susceptible to HRV than suprabasal cells, suggesting that differentiation is associated with resistance to HRV infection 31. Taken together, these studies indicate that an intact differentiated epithelium is resistant to HRV infection and that damage to the superficial cells of the respiratory pseudocolumnar epithelium allows HRV to reach and infect the more susceptible basal epithelial cells.

The reason for the increased susceptibility of bronchial epithelial (HBE) cells to HRV compared with nasal (HNE) cells is unclear. Our HBE and HNE cell cultures differed modestly in their electrical properties. HNE tended to have slightly higher electrical resistance than HBE cultures (366 versus 195 Ω.cm2), but were morphologically similar (see Figure 1). A progressive proximal-to-distal airway decline in the electrical properties of the epithelium has been previously reported from comparison of the potential difference across the nasal, tracheal, and bronchial mucosa in vitro 32, 33. This difference can not be explained by technique. To minimize the chances of differences in level of differentiation, HBEs and HNEs were collected and cultured in parallel under identical conditions regarding the density of cells plated, time to passage the cells (passage one), time to differentiation and duration of infection. The cells were infected with a single HRV-16 batch using the same MOI (1.0), and the samples of HNE and HBE cells from the same subject were processed together. Despite similar culture conditions, the resulting higher electrical resistance in HNEs than in HBEs raises the hypothesis that HNEs could form a tighter barrier or could express higher levels of ion channels than HBEs, which in turn could possibly increase protection against HRV infection. Another hypothesis to explain the higher susceptibility of HBEs to HRV infection compared with HNEs is differences in innate immunity to RNA viruses. HNE and HBE cells could express different amounts of virus-RNA sensing molecules such as toll-like receptors and helicases, or of anti-viral molecules12,35,36 such as human β-defensin (HBD)-2 and interferons. These hypotheses need to be further explored.

Cytotoxicity induced by HRV did not seem to be a confounder in our experiments. HRV did not affect cell viability significantly because epithelial electrical properties declined only modestly and to a similar extent in HNEs and HBEs after HRV infection. We also found few cells infected with HRV-16 by immunocytochemistry in either cell type, although the frequency of infected cells was higher in bronchial cultures than in nasal cultures. The good quality of RNA isolated from cells and non-significant alteration of expression of most genes related to apoptosis also indicate that cell viability was not affected to a large extent. This is in agreement with previous studies on confluent cultures using other rhinovirus strains 9, 11, 16, 34, although RV-49 can be cytotoxic 10. It is also in agreement with studies of nasal and bronchial biopsies of patients with community-acquired or experimental colds, which have shown little evidence of epithelial cytotoxicity 6, 9

We did not find statistically higher response to HRV-16 infection in cultures from asthmatic subject group compared with cultures from healthy group as described by Wark et al 18, and Contoli et al 26. These researchers also studied subjects with mild asthma, but found that undifferentiated bronchial epithelial cells to have a markedly enhanced susceptibility to HRV infection that was associated with impaired production of IFN-β1, type III IFNs, and induction of apoptosis compared with cells from healthy subjects 18, 26. A potential explanation for our discrepant results could be that culturing in conditions to induce differentiation for 3–4 weeks away from the original airway microenvironment could have generated cells with similar phenotypes between groups. However, if this were true, we would likely not have observed the marked differences between nasal and bronchial cells. In addition, Wark and Contoli et al.18, 26 also grew their cells in vitro for few weeks before conducting their experiments. While we believe that the difference in our findings stems from our use of conditions that favor epithelial cell differentiation, we acknowledge that the infection of so few cells in our cultured cells may compromise our ability to detect differences in upregulation of the genes important in anti-viral defense. We can say, though, that our methods allowed productive infection of HBEs and detection of upregulation of other genes previously described as upregulated by viral infection (e.g., RANTES, IL-8, PKR) 37.

In summary, our data indicate that HBE cells are more susceptible to HRV infection than human HNE cells, in cultures from the same individual. Our data do not show a difference in the susceptibility to HRV infection of nasal or bronchial epithelial cells from asthmatic vs. non-asthmatic, healthy subjects. What remains to be determined, however, is the mechanism for the differences in viral infection between HBE and HNE cells. If our findings apply to native epithelium in vivo, further analysis of the mechanisms responsible for the greater resistance of nasal epithelial cells to viral infection may suggest approaches for prevention or treatment of acute viral bronchitis in healthy people and of virally-induced exacerbations of asthma, COPD, cystic fibrosis, and other airway diseases.

Acknowledgments

This work was supported by NIH grant P01AI050496. PCA and SF are currently supported by the Ernest S. Bazley Grant to Northwestern University.

We are grateful to Samantha Donnelly, Ph.D. and Jenny Shen, B.S. for their assistance in gene expression profiling.

List of Abbreviations

TCID50
Tissue culture infective dose
HBE
Human bronchial epithelial
HNE
Human nasal epithelial
HRV
Human rhinovirus
Rte
transepithelial resistance
Vte
transepithelial potential difference
Ieq
equivalent short circuit current
ICAM-1
intercellular adhesion molecule-1

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Bmj. 1993;307:982–6. [PMC free article] [PubMed]
2. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child. 1995;73:117–20. [PMC free article] [PubMed]
3. Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J. 2000;16:677–83. [PubMed]
4. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. Bmj. 1995;310:1225–9. [PMC free article] [PubMed]
5. Bardin PG, Johnston SL, Sanderson G, Robinson BS, Pickett MA, Fraenkel DJ, et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol. 1994;10:207–13. [PubMed]
6. Arruda E, Boyle TR, Winther B, Pevear DC, Gwaltney JM, Jr, Hayden FG. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis. 1995;171:1329–33. [PubMed]
7. Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med. 2005;171:645–51. [PubMed]
8. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155:1159–61. [PubMed]
9. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181:1875–84. [PubMed]
10. Schroth MK, Grimm E, Frindt P, Galagan DM, Konno SI, Love R, et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol. 1999;20:1220–8. [PubMed]
11. Terajima M, Yamaya M, Sekizawa K, Okinaga S, Suzuki T, Yamada N, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol. 1997;273:L749–59. [PubMed]
12. Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D, et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol. 2006;34:192–203. [PMC free article] [PubMed]
13. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology. 1995;84:16–20. [PubMed]
14. Winther B, Gwaltney JM, Jr, Mygind N, Turner RB, Hendley JO. Sites of rhinovirus recovery after point inoculation of the upper airway. Jama. 1986;256:1763–7. [PubMed]
15. Winther B, Gwaltney JM, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis. 1990;141:839–45. [PubMed]
16. Mosser AG, Brockman-Schneider R, Amineva S, Burchell L, Sedgwick JB, Busse WW, et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis. 2002;185:734–43. [PubMed]
17. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831–4. [PubMed]
18. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937–47. [PMC free article] [PubMed]
19. Lopez-Souza N, Dolganov G, Dubin R, Sachs LA, Sassina L, Sporer H, et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol. 2004;286:L373–81. [PubMed]
20. Fleming HE, Little FF, Schnurr D, Avila PC, Wong H, Liu J, et al. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med. 1999;160:100–8. [PubMed]
21. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol. 1991;88:425–534. [PubMed]
22. Lopez-Souza N, Avila PC, Widdicombe JH. Polarized cultures of human airway epithelium from nasal scrapings and bronchial brushings. In Vitro Cell Dev Biol Anim. 2003;39:266–9. [PubMed]
23. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol. 1991;88:808–14. [PubMed]
24. Lennette DA. Diagnostic procedures for viral, rickettsial and chlamydial infections. Washington, D.C: APHA; 1995. General principles for laboratory diagnosis of viral, rickettsial, chlamydial infections.
25. Dolganov GM, Woodruff PG, Novikov AA, Zhang Y, Ferrando RE, Szubin R, et al. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Res. 2001;11:1473–83. [PubMed]
26. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12:1023–6. [PubMed]
27. Papadopoulos NG, Johnston SL. Rhinoviruses as pathogens of the lower respiratory tract. Can Respir J. 2000;7:409–14. [PubMed]
28. Yamaya M, Finkbeiner WE, Chun SY, Widdicombe JH. Differentiated structure and function of cultures from human tracheal epithelium. Am J Physiol. 1992;262:L713–24. [PubMed]
29. Yoon JH, Moon HJ, Seong JK, Kim CH, Lee JJ, Choi JY, et al. Mucociliary differentiation according to time in human nasal epithelial cell culture. Differentiation. 2002;70:77–83. [PubMed]
30. Widdicombe JH, Sachs LA, Finkbeiner WE. Effects of growth surface on differentiation of cultures of human tracheal epithelium. In Vitro Cell Dev Biol Anim. 2003;39:51–5. [PubMed]
31. Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol. 2008;38:517–23. [PMC free article] [PubMed]
32. Ballard ST, Schepens SM, Falcone JC, Meininger GA, Taylor AE. Regional bioelectric properties of porcine airway epithelium. J Appl Physiol. 1992;73:2021–7. [PubMed]
33. Boucher RC, Stutts MJ, Gatzy JT. Regional differences in bioelectric properties and ion flow in excised canine airways. J Appl Physiol. 1981;51:706–14. [PubMed]
34. Bianco A, Sethi SK, Allen JT, Knight RA, Spiteri MA. Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J. 1998;12:619–26. [PubMed]
35. Proud D, Sanders SP, Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol. 2004;172:4637–45. [PubMed]
36. Hunt SL, Hsuan JJ, Totty N, Jackson RJ. unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA. Genes Dev. 1999;13:437–48. [PubMed]
37. Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol. 2004;75:5–17. [PubMed]